Saturday, July 13, 2019 4:27:07 PM
Significant good? Because that just seems to highlight the fact that they haven't found a lot of takers for their technology. Aren't there experienced delayed release pill designers that IPIX could be using?
"BDD, the developer of OraLogiK, is based in Scotland. Relatively close to IPIX's European subsidiary's office"
Relative to what? It's an 8 hour trip including the ferry ride. Beverly is closer to Baltimore than Glasgow is to Cork.
"CoreRX, an American company based in Floida, also develops oral segmental release pills with its multilayered technology."
Clearwater, to be specific. In fact the CEO lives closer to CoreRx than Cork is to Glasgow, a lot closer. Why aren't they doing the pill? Leo could sashay on over every once in a while to see how it's going.
"Dr. Bertolino led the early clinical program of Cosentyx™ (secukinumab)"...but he didn't see the Prurisol failure coming for some reason.
https://www.cosentyx.com/
Dr. B left Novartis after 5 years, landing at Revance (which still doesn't have an approved drug). Was his departure from Novartis by choice (Was his departure from Revance amenable, for that matter?)? I wouldn't be asking such a FUDdy question if you and others didn't speculate that "When you add Dr Bertilino's past connection to Novartis there is a lot of circumstantial evidence to suspect Novartis as one of IPIX suitors."
BDD/Novartis/IPIX is a decent connection. Bertolino may add to OR detract from it.
But can it core A apple?
Yes Ralph, of course it can core A apple.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM